v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2024 $ 440,004 $ 168 $ 944,891 $ (502,315) $ (2,740)
Balance (in shares) at Dec. 31, 2024   168,029      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (14,817)     (14,817)  
Other comprehensive income (loss) 1,224       1,224
Stock-based compensation 24,585   24,585    
Exercise of common stock options 382 $ 2 380    
Exercise of common stock options (in shares)   1,635      
Vesting of restricted stock units (11,808) $ 1 (11,809)    
Vested restricted stock units (in shares)   840      
Balance at Mar. 31, 2025 439,570 $ 171 958,047 (517,132) (1,516)
Balance (in shares) at Mar. 31, 2025   170,504      
Balance at Dec. 31, 2025 429,683 $ 173 996,628 (568,456) 1,338
Balance (in shares) at Dec. 31, 2025   173,179      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (10,892)     (10,892)  
Other comprehensive income (loss) (1,080)       (1,080)
Stock-based compensation 15,303   15,303    
Exercise of common stock options $ 690 $ 1 689    
Exercise of common stock options (in shares) 476 476      
Vesting of restricted stock units $ (2,780)   (2,780)    
Vested restricted stock units (in shares)   477      
Balance at Mar. 31, 2026 $ 430,924 $ 174 $ 1,009,840 $ (579,348) $ 258
Balance (in shares) at Mar. 31, 2026   174,132